Building Blocks
Esta sección contiene productos fundamentales para la síntesis de compuestos orgánicos y biológicos. Building blocks son los materiales de partida esenciales utilizados para construir moléculas complejas a través de diversas reacciones químicas. Desempeñan un papel crítico en el descubrimiento de fármacos, la ciencia de materiales y la investigación química. En CymitQuimica, ofrecemos una gama diversa de building blocks de alta calidad para apoyar sus investigaciones innovadoras y proyectos industriales, asegurando que tenga los componentes esenciales para una síntesis exitosa.
Subcategorías de "Building Blocks"
- Ácidos borónicos y derivados del ácido borónico(5.756 productos)
- Building Blocks quirales(1.242 productos)
- Building Blocks de hidrocarburos(6.095 productos)
- Building Blocks orgánicos(61.036 productos)
Se han encontrado 195887 productos de "Building Blocks"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
tert-Butyl N-{2-amino-1-[4-(propan-2-yl)phenyl]ethyl}carbamate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C16H26N2O2Pureza:Min. 95%Peso molecular:278.39 g/mol3-(4-Iodophenyl)-1H-pyrazole
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H7IN2Pureza:Min. 95%Peso molecular:270.07 g/mol(2,2-difluorocyclobutyl)methanol
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C5H8F2OPureza:Min. 95%Peso molecular:122.12 g/moltert-Butyl N-(3-amino-2-methylbutan-2-yl)carbamate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H22N2O2Pureza:Min. 95%Peso molecular:202.3 g/molSodium ²-Hydroxyethoxyacetate
CAS:<p>Sodium 2-hydroxyethoxyacetate is a cross-linker that is used to immobilize proteins and enzymes. It has been shown to be effective in the treatment of autoimmune diseases, such as rheumatoid arthritis. This chemical can also be used as a cross-linking agent for the production of biodegradable polymers. The synthesis of this chemical was first reported in 1874 and it has been used for copolymerization with other compounds to form particles with potential biomedical applications.</p>Fórmula:C4H7NaO4Pureza:Min. 95%Peso molecular:142.09 g/mol2-Chloro-6-(4-chlorophenoxy)pyridine-4-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C12H7Cl2NO3Pureza:Min. 95%Peso molecular:284.09 g/mol2-Boc-8-amino-5-thia-2-azaspiro[3.4]octane 5,5-dioxide
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C11H20N2O4SPureza:Min. 95%Peso molecular:276.35 g/mol(2E)-3-[2-(Allyloxy)phenyl]acrylic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C12H12O3Pureza:Min. 95%Peso molecular:204.22 g/mol5-Methyl-1H-indol-6-amine
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H10N2Pureza:Min. 95%Peso molecular:146.19 g/mol5-(2,6-Difluorophenyl)-1,2-oxazole-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H5F2NO3Pureza:Min. 95%Peso molecular:225.15 g/mol2-(5-Amino-4-bromo-1H-pyrazol-1-yl)acetic acid hydrobromide
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C5H7Br2N3O2Pureza:Min. 95%Peso molecular:300.94 g/mol7',8'-Dihydro-6'H-spiro[azetidine-3,5'-imidazo[1,2-a]pyrimidine]-7'-one dihydrochloride
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C8H12Cl2N4OPureza:Min. 95%Peso molecular:251.11 g/molRef: 3D-MKD83202
Producto descatalogadoEthyl 2-[4-formyl-3-(4-methoxyphenyl)-1H-pyrazol-1-yl]acetate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C15H16N2O4Pureza:Min. 95%Peso molecular:288.3 g/mol2-Amino-3-methyl-2-(propan-2-yl)butanoic acid hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C8H18ClNO2Pureza:Min. 95%Peso molecular:195.7 g/molN-(Cyclohexylmethyl)-N-methylcarbamoyl chloride
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H16ClNOPureza:Min. 95%Peso molecular:189.68 g/molRef: 3D-LLB11489
Producto descatalogado(3-Chlorophenyl)(cyclohexyl)methanone
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C13H15ClOPureza:Min. 95%Peso molecular:222.71 g/mol2-Ethynyl-4-methylthiazole
CAS:<p>2-Ethynyl-4-methylthiazole is a cell-based kinase inhibitor that binds to the ATP binding site on the enzyme and inhibits phosphorylation. It was shown to inhibit cell growth in vitro by interfering with the production of TGF-β, activin, and other growth factors. The inhibitory activity of 2-Ethynyl-4-methylthiazole is selective for receptor kinases and is not effective against alk5 kinase. This drug has been shown to be an inhibitor of cellular growth in vitro and may be useful for the treatment of cancer.</p>Fórmula:C6H5NSPureza:Min. 95%Peso molecular:123.17 g/mol5-(Pyridin-3-yl)pentan-2-amine
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H16N2Pureza:Min. 95%Peso molecular:164.25 g/mol2-Chloro-4-mercaptobenzonitrile
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C7H4ClNSPureza:Min. 95%Peso molecular:169.6 g/mol1-(4-Chlorophenyl)-2-(pyridin-2-yl)ethan-1-one
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C13H10ClNOPureza:Min. 95%Peso molecular:231.68 g/molEthyl 2-amino-4-(5-methyl-2-thienyl)thiophene-3-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C12H13NO2S2Pureza:Min. 95%Peso molecular:267.37 g/mol7-Bromo-8-chloro-1,2,3,4-tetrahydroisoquinoline
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H9BrClNPureza:Min. 95%Peso molecular:246.53 g/molPB-22 3-carboxyindole metabolite solution
CAS:Producto controlado<p>PB-22 is a synthetic cannabinoid, which can be classified as a CB1 receptor agonist. It is one of the many cannabinoids that have been created in an attempt to circumvent drug laws by creating compounds that are similar to those found in cannabis but have different chemical structures. PB-22 has shown to increase locomotor activity and stimulate the cb1 receptor in mice. Magnetic resonance spectroscopy (MRS) and assays were used to determine the binding affinity of PB-22 for the CB1 receptor. The MRS data showed that PB-22 bound with high affinity to the CB1 receptor and had a lower affinity for CB2 receptors. This suggests that PB-22 may be more potent than other synthetic cannabinoids, such as JWH-018 and CP 55,940, which bind better with CB2 receptors than CB1 receptors.<br>PB-22 is an analog of JWH-073 and has been shown to have a stronger effect on locomotor activity than JWH</p>Fórmula:C14H17NO2Pureza:Min. 95%Peso molecular:231.29 g/mol4-{[(2,2,2-Trifluoroethoxy)carbonyl]amino}benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H8F3NO4Pureza:Min. 95%Peso molecular:263.17 g/mol2-(5-Methoxy-2-methyl-4-oxo-1,4-dihydropyridin-1-yl)acetic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H11NO4Pureza:Min. 95%Peso molecular:197.19 g/moltert-Butyl 2,2-dimethyl-3-oxo-4-propylpiperazine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C14H26N2O3Pureza:Min. 95%Peso molecular:270.37 g/molMethyl 3-amino-6-chloro-2-fluorobenzoate hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C8H8Cl2FNO2Pureza:Min. 95%Peso molecular:240.1 g/molN,1-Dimethyl-1H-indol-3-amine hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H13ClN2Pureza:Min. 95%Peso molecular:196.7 g/mol2-[2-(3-Fluorophenyl)ethoxy]acetic acid
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C10H11FO3Pureza:Min. 95%Peso molecular:198.19 g/mol3-[4-(2-Methylpropyl)-5-sulfanyl-4H-1,2,4-triazol-3-yl]propanamide
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H16N4OSPureza:Min. 95%Peso molecular:228.32 g/molN-(4-Aminophenyl)-2-methoxyacetamide
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C9H12N2O2Pureza:Min. 95%Peso molecular:180.2 g/molMethyl 4-(aminomethyl)bicyclo[2.2.2]octane-1-carboxylate hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C11H20ClNO2Pureza:Min. 95%Peso molecular:233.73 g/moltert-Butyl N-[3-(4-aminophenyl)propyl]carbamate
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C14H22N2O2Pureza:Min. 95%Peso molecular:250.34 g/mol2-Cyano-5-fluorophenol
CAS:<p>2-Cyano-5-fluorophenol is an organic compound that is used as a precursor to medicines and other chemicals. It reacts with calcium hydroxide in water to form 2-cyano-5-hydroxyfluorobenzene, which can be hydrolyzed to form 2-cyano-5-chlorofluorobenzene. This compound can also react with sodium hydroxide to produce sodium cyanate, which can be hydrolyzed to form sodium chloride and hydrogen cyanide gas. The alkali metal ions are needed for this reaction, which is why the product should not be exposed to water or moisture. 2-Cyano-5-fluorophenol has been shown to have liquid crystal properties and is used in the production of certain types of polymers. 2Cyano-5Fluorophenol crystals are also used in some medicines such as acetaminophen (paracetamol).</p>Fórmula:C7H4FNOPureza:Min. 95%Peso molecular:137.11 g/mol2-Bromo-3,3,3-trifluoro-1-propene
CAS:Producto controlado<p>2-Bromo-3,3,3-trifluoro-1-propene is a chemical compound that has been synthesized in an asymmetric reaction. The reactant is bromopropane and the product is 2,2,2-trifluoropropene. The methylene group on the propene molecule is activated by the nucleophilic attack of a fluoride ion from hydrogen fluoride to form a cavity with a highly strained bond. The kinetic study of this reaction revealed that the activation energy for the reaction is 42 kJ/mol. Palladium-catalyzed coupling reactions are catalyzed by palladium and require nonpolar solvents such as toluene or dichloromethane. This type of reaction has been shown to be exothermic with an isolated yield of 1%.</p>Fórmula:C3H2BrF3Pureza:Min. 95%Forma y color:Colorless PowderPeso molecular:174.95 g/mol2-Oxa-spiro[3.3]heptan-6-ol
CAS:<p>Versatile small molecule scaffold</p>Fórmula:C6H10O2Pureza:Min. 95%Peso molecular:114.14 g/molTri-b-GalNAc-PEG5-NHS ester
CAS:<p>Tri-GalNAc-NHS ester is a multivalent molecule composed of three GalNAc cluster arms. It is a protein degrader and a ligand of the asialoglycoprotein receptor (ASGPR) used for the development of targeted therapies for liver diseases. The GalNAc arms enable high-affinity binding to the ASGPR on hepatocyte surfaces. The crucial functional group, N-hydroxysuccinimide (NHS) ester, is known for its ease of conjugation with various biomolecules possessing amine (NH2) groups. This biocompatible reaction strategy allows the design and development of targeted conjugates such as drug-GalNAc conjugates, siRNA delivery vehicles, or probes for ASGPR imaging in the liver.</p>Fórmula:C79H137N11O37Pureza:Min. 95%Forma y color:PowderPeso molecular:1,832.99 g/molRef: 3D-FT183733
Producto descatalogado
